BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31662298)

  • 21. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Learning from mouse models of MLL fusion gene-driven acute leukemia.
    Schwaller J
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathways driven by ETO2-GLIS2 in aggressive pediatric leukemia.
    Thirant C; Lopez C; Malinge S; Mercher T
    Mol Cell Oncol; 2017; 4(6):e1345351. PubMed ID: 29209645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.
    Agrawal-Singh S; Koschmieder S; Gelsing S; Stocking C; Stehling M; Thiede C; Thoennissen NH; Köhler G; Valk PJ; Delwel R; Mills K; Bäumer N; Tickenbrock L; Hansen K; Berdel WE; Müller-Tidow C; Serve H
    Blood; 2010 Jun; 115(22):4507-16. PubMed ID: 20215640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
    Masetti R; Bertuccio SN; Pession A; Locatelli F
    Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
    Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
    Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chromatin-remodeling factor
    Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
    Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model.
    Tijchon E; Yi G; Mandoli A; Smits JGA; Ferrari F; Heuts BMH; Wijnen F; Kim B; Janssen-Megens EM; Schuringa JJ; Martens JHA
    PLoS One; 2019; 14(12):e0226435. PubMed ID: 31869378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.
    Endo A; Tomizawa D; Aoki Y; Morio T; Mizutani S; Takagi M
    Cancer Sci; 2016 Dec; 107(12):1745-1754. PubMed ID: 27627705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
    Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
    Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Larson Gedman A; Zhang J; Koss CS; Marada S; Ta HQ; Chen SC; Su X; Ogden SK; Dang J; Wu G; Gupta V; Andersson AK; Pounds S; Shi L; Easton J; Barbato MI; Mulder HL; Manne J; Wang J; Rusch M; Ranade S; Ganti R; Parker M; Ma J; Radtke I; Ding L; Cazzaniga G; Biondi A; Kornblau SM; Ravandi F; Kantarjian H; Nimer SD; Döhner K; Döhner H; Ley TJ; Ballerini P; Shurtleff S; Tomizawa D; Adachi S; Hayashi Y; Tawa A; Shih LY; Liang DC; Rubnitz JE; Pui CH; Mardis ER; Wilson RK; Downing JR
    Cancer Cell; 2012 Nov; 22(5):683-97. PubMed ID: 23153540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
    Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
    Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
    Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
    Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
    Thanasopoulou A; Tzankov A; Schwaller J
    Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
    Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
    Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
    Stubbs MC; Krivtsov AV
    Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.